User profiles for Pamela J. McLean

Pamela McLean

Mayo Clinic
Verified email at mayo.edu
Cited by 34312

[HTML][HTML] Gaucher disease glucocerebrosidase and α-synuclein form a bidirectional pathogenic loop in synucleinopathies

JR Mazzulli, YH Xu, Y Sun, AL Knight, PJ McLean… - Cell, 2011 - cell.com
Parkinson's disease (PD), an adult neurodegenerative disorder, has been clinically linked
to the lysosomal storage disorder Gaucher disease (GD), but the mechanistic connection is …

Sirtuin 2 inhibitors rescue α-synuclein-mediated toxicity in models of Parkinson's disease

…, CB Volk, MM Maxwell, JC Rochet, PJ McLean… - science, 2007 - science.org
The sirtuins are members of the histone deacetylase family of proteins that participate in a
variety of cellular functions and play a role in aging. We identified a potent inhibitor of sirtuin 2 (…

[HTML][HTML] Exosomal cell-to-cell transmission of alpha synuclein oligomers

…, L Zhu, CR Vanderburg, PJ McLean - Molecular …, 2012 - Springer
Background Aggregation of alpha-synuclein (αsyn) and resulting cytotoxicity is a hallmark of
sporadic and familial Parkinson’s disease (PD) as well as dementia with Lewy bodies, with …

[HTML][HTML] Hsp70 reduces α-synuclein aggregation and toxicity

…, Y Shin, E Masliah, BT Hyman, PJ McLean - Journal of Biological …, 2004 - ASBMB
Aggregation and cytotoxicity of misfolded α-synuclein is postulated to be crucial in the
disease process of neurodegenerative disorders such as Parkinson's disease and DLB (dementia …

Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy

…, EA Stern, PJ McLean, J Skoch… - Journal of …, 2005 - Soc Neuroscience
Accumulation of amyloid-β (Aβ) into senile plaques in Alzheimer's disease (AD) is a hallmark
neuropathological feature of the disorder, which likely contributes to alterations in neuronal …

[HTML][HTML] Formation of toxic oligomeric α-synuclein species in living cells

…, M Koker, F Carvalho, BT Hyman, PJ McLean - PloS one, 2008 - journals.plos.org
Background Misfolding, oligomerization, and fibrillization of α-synuclein are thought to be
central events in the onset and progression of Parkinson's disease (PD) and related disorders. …

Direct quantification of CSF α-synuclein by ELISA and first cross-sectional study in patients with neurodegeneration

…, W Schulz-Schaeffer, HA Kretzschmar, PJ McLean… - Experimental …, 2008 - Elsevier
Because accumulation of α-synuclein (αS) in the brain is a hallmark of Parkinson disease (PD)
and related disorders, we examined its occurrence in human cerebrospinal fluid (CSF). …

Distinct roles in vivo for the ubiquitin–proteasome system and the autophagy–lysosomal pathway in the degradation of α-synuclein

…, E Masliah, BT Hyman, PJ McLean… - Journal of …, 2011 - Soc Neuroscience
… Correspondence should be addressed to either of the following: Pamela J. McLean,
MassGeneral Institute for Neurodegenerative Disease, Massachusetts General Hospital, Harvard …

TorsinA and heat shock proteins act as molecular chaperones: suppression of α‐synuclein aggregation

PJ McLean, H Kawamata, S Shariff… - Journal of …, 2002 - Wiley Online Library
TorsinA, a protein with homology to yeast heat shock protein104, has previously been
demonstrated to colocalize with α‐synuclein in Lewy bodies, the pathological hallmark of …

[HTML][HTML] The co-chaperone carboxyl terminus of Hsp70-interacting protein (CHIP) mediates α-synuclein degradation decisions between proteasomal and lysosomal …

…, J Klucken, C Patterson, BT Hyman, PJ McLean - Journal of Biological …, 2005 - ASBMB
α-Synuclein is a major component of Lewy bodies, the pathological hallmark of Parkinson
disease, dementia with Lewy bodies, and related disorders. Misfolding and aggregation of α-…